FDA Class II · Drug · August 12, 2026
Dicyclomine Hydrochloride Capsules recall — Aurobindo Pharma USA Inc
shortfill; reports of empty capsules.
Official ID D-0733-2026 · Official record ↗
Aurobindo Pharma USA recalls
Recall found. Aurobindo Pharma USA is named in FDA Class II recall D-0733-2026 covering Dicyclomine Hydrochloride Capsules. Hazard: shortfill; reports of empty capsules. Identifying details: Batch # DMC125018A, Exp Date: 07/2027.. Status: Ongoing.
Models with recalls
All Aurobindo Pharma USA recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked September 7, 2026 at 6:00 AM UTC.